Orit MARKOWITZ 医师

Dr. Orit Markowitz is a leading dermatologist, skin cancer specialist, CEO, and Founder of OptiSkin. She has been called a dermatologic pioneer for her groundbreaking work developing minimally invasive diagnostic and treatment protocols for skin cancer.

Over the past decade, Dr. Markowitz has served as Director of Pigmented Lesions and Skin Cancer at both Mount Sinai Department of Dermatology and Brooklyn Veterans Hospital of Downstate University Medical Center, as well as Associate Professor of Dermatology at Mount Sinai and SUNY Downstate University Medical Center.

In 2021, Dr. Markowitz opened OptiSkin, a state-of-the-art treatment, training, and research center to help bring her signature nonsurgical skin cancer care to more patients and physicians.

Dr. Markowitz is considered a leading educator in noninvasive skin cancer therapies. She has directed imaging courses for the American Academy of Dermatology (AAD), trains all residents in the greater New York area on dermoscopy, and wrote A Practical Guide to Dermoscopy, the leading handbook on the topic. Dr. Markowitz has also lectured at numerous AAD conferences, is President of the International Optical Coherence Tomography Society, Chair of the AAD’s Quality Assurance and Education Committee Cutaneous Imaging Group, and was the chair of the World Congress of Confocal Microscopy Conference held in New York City in May 2021.

Considered one of the world’s leading researchers in nonsurgical skin cancer treatment, Dr. Markowitz opened OptiSkin, in part, to act as her primary research lab. Dr. Markowitz has acted as principal investigator in multiple U.S. clinical trials studying noninvasive imaging in skin cancer, precancer, psoriasis, eczema, and topical and injectable collagen stimulation. Her most recent funded imaging research includes early diagnosis and optimal management of skin cancer and prognostic indicators of medications on disease, such as field cancerization, psoriasis, atopic dermatitis, nail fungus, allergy patch testing, and regenerative collagen production.